×
Entrez Id: 54790
Gene Symbol: TET2
TET2
Malignant neoplasm of prostate
0.350
Biomarker
CTD_human
Among men carrying two A alleles at rs7679673 in TET2 , the risk of prostate cancer associated with high aldrin use was 3.67 times those with no use (95% CI: 1.43, 9.41) (P-interaction= 0.006).
23593118 2013
×
Entrez Id: 23301
Gene Symbol: EHBP1
EHBP1
Malignant neoplasm of prostate
0.420
Biomarker
CTD_human
Among men carrying two T alleles at rs2710647 in EH domain binding protein 1 (EHBP1 ) SNP, the risk of prostate cancer in those with high malathion use was 3.43 times those with no use (95% CI: 1.44-8.15) (P-interaction= 0.003).
23593118 2013
×
Entrez Id: 2938
Gene Symbol: GSTA1
GSTA1
Malignant neoplasm of prostate
0.330
Biomarker
CTD_human
Among smokers, the frequency of the GSTA1 *A/*B or *B/*B genotype in patients with prostate cancer (27.8%) showed a statistically significant increase compared with the control group frequency (18.2%; odds ratio [OR] =1.72; 95% CI, 1.01-2.94).
15616829 2005
×
Entrez Id: 3817
Gene Symbol: KLK2
KLK2
Malignant neoplasm of prostate
0.400
Biomarker
CTD_human
Among the SNPs studied, the A allele of the KLK2 -SNP1 (G>A, rs2664155) and the T allele of the KLK2 -SNP5 (C>T, rs198977) polymorphisms showed positive associations with prostate cancer , adjusted ORs for KLK2 -SNP1 AG and AA genotypes being 1.4 [95% confidence interval (95% CI), 1.2-1.8; P=0.002] and for KLK2 -SNP5 TT or CT genotypes being 1.3 (95% CI, 1.1-1.6; P=0.05).
17085659 2006
×
Entrez Id: 43
Gene Symbol: ACHE
ACHE
Malignant neoplasm of prostate
0.300
Biomarker
CTD_human
Amphiphilic dimers and monomers and hydrophilic dimers of AChE were identified in BHP and PC tissues.
20356562 2010
×
Entrez Id: 2130
Gene Symbol: EWSR1
EWSR1
Malignant neoplasm of prostate
0.310
Biomarker
CTD_human
An Interaction with Ewing's Sarcoma Breakpoint Protein EWS Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in Prostate Cancer .
27783944 2016
×
Entrez Id: 2115
Gene Symbol: ETV1
ETV1
Malignant neoplasm of prostate
0.400
Biomarker
CTD_human
An Interaction with Ewing's Sarcoma Breakpoint Protein EWS Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in Prostate Cancer.
27783944 2016
×
Entrez Id: 2118
Gene Symbol: ETV4
ETV4
Malignant neoplasm of prostate
0.400
Biomarker
CTD_human
An Interaction with Ewing's Sarcoma Breakpoint Protein EWS Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in Prostate Cancer.
27783944 2016
×
Entrez Id: 2078
Gene Symbol: ERG
ERG
Malignant neoplasm of prostate
0.400
Biomarker
CTD_human
An Interaction with Ewing's Sarcoma Breakpoint Protein EWS Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in Prostate Cancer.
27783944 2016
×
Entrez Id: 2119
Gene Symbol: ETV5
ETV5
Malignant neoplasm of prostate
0.390
Biomarker
CTD_human
An Interaction with Ewing's Sarcoma Breakpoint Protein EWS Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in Prostate Cancer.
27783944 2016
×
Entrez Id: 354
Gene Symbol: KLK3
KLK3
Malignant neoplasm of prostate
0.500
Biomarker
CTD_human
An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer.
12644816 2003
×
Entrez Id: 2247
Gene Symbol: FGF2
FGF2
Malignant neoplasm of prostate
0.400
Biomarker
CTD_human
An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer.
12644816 2003
×
Entrez Id: 4292
Gene Symbol: MLH1
MLH1
Malignant neoplasm of prostate
0.400
Biomarker
CTD_human
Analysis of candidate genes for prostate cancer.
15583422 2004
×
Entrez Id: 3249
Gene Symbol: HPN
HPN
Malignant neoplasm of prostate
0.400
Biomarker
CTD_human
Analysis of candidate genes for prostate cancer.
15583422 2004
×
Entrez Id: 2014
Gene Symbol: EMP3
EMP3
Malignant neoplasm of prostate
0.300
Biomarker
CTD_human
Analysis of candidate genes for prostate cancer.
15583422 2004
×
Entrez Id: 858
Gene Symbol: CAV2
CAV2
Malignant neoplasm of prostate
0.300
Biomarker
CTD_human
Analysis of candidate genes for prostate cancer.
15583422 2004
×
Entrez Id: 8537
Gene Symbol: BCAS1
BCAS1
Malignant neoplasm of prostate
0.300
Biomarker
CTD_human
Analysis of candidate genes for prostate cancer.
15583422 2004
×
Entrez Id: 5567
Gene Symbol: PRKACB
PRKACB
Malignant neoplasm of prostate
0.300
Biomarker
CTD_human
Androgen dependent regulation of protein kinase A subunits in prostate cancer cells.
16949795 2007
×
Entrez Id: 10257
Gene Symbol: ABCC4
ABCC4
Malignant neoplasm of prostate
0.340
Biomarker
CTD_human
Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells.
17003774 2007
×
Entrez Id: 367
Gene Symbol: AR
AR
Malignant neoplasm of prostate
1.000
Therapeutic
CTD_human
Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells.
17003774 2007
×
Entrez Id: 367
Gene Symbol: AR
AR
Malignant neoplasm of prostate
1.000
Biomarker
CTD_human
Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells.
17003774 2007
×
Entrez Id: 354
Gene Symbol: KLK3
KLK3
Malignant neoplasm of prostate
0.500
Biomarker
CTD_human
Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells.
17003774 2007
×
Entrez Id: 2146
Gene Symbol: EZH2
EZH2
Malignant neoplasm of prostate
0.400
Biomarker
CTD_human
Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells.
17003774 2007
×
Entrez Id: 4609
Gene Symbol: MYC
MYC
Malignant neoplasm of prostate
0.400
Biomarker
CTD_human
Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation.
23704919 2013
×
Entrez Id: 8202
Gene Symbol: NCOA3
NCOA3
Malignant neoplasm of prostate
0.400
Biomarker
CTD_human
Androgen receptors in prostate cancer.
12237244 2002